Study

EORTC-62072

A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy.

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 01-Oct-2008
Date Step1 close: 08-Mar-2010

Data management at EORTC

Yes

Design

Phase 3
Randomized blind

Targeted Sample size

All Groups: 255

Protocol summary

http://clinicaltrials.gov/study/NCT00794521

NCT number

NCT00794521

EudraCT

2008-001307-33